ARTICLE | Company News
Ventria deal
December 10, 2012 8:00 AM UTC
Ventria acquired exclusive, royalty-free rights in the U.S., France and Canada to undisclosed patents related to recombinant human lactoferrin (rhLF) for an undisclosed one-time payment. The patents ...